CoChat

Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis

Open access
Tang, Min, Chen, Yang, Li, Bingrui, Sugimoto, Hikaru, Yang, Sujuan, Yang, Changqing, LeBleu, Valerie S., McAndrews, Kathleen M., Kalluri, Raghu · 2021 · The FASEB Journal
Cited by 86

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Hepatic fibrosis is a wound healing response that results in excessive extracellular matrix (ECM) accumulation in response to chronic hepatic injury. Signal transducer and activator of transcription 3 (STAT3) is an important transcription factor associated with the pathogenesis of liver fibrosis. Though a promising potential therapeutic target, there are no specific drug candidates for STAT3. Exosomes are extracellular vesicles generated by all cell types with a capacity to efficiently enter cells across different biological barriers. Here, we utilize exosomes as delivery conduit to specifically target STAT3 in liver fibrosis. Exosomes derived from clinical grade fibroblast‐like mesenchymal stem cells (MSCs) were engineered to carry siRNA or antisense oligonucleotide (ASO) targeting STAT3 (iExo siRNA‐STAT3 or iExo mASO‐STAT3 ). Compared to scrambled siRNA control, siRNA‐STAT3, or ASO‐STAT3, iExo siRNA‐STAT3 or iExo mASO‐STAT3 showed enhanced STAT3 targeting efficiency. iExo siRNA‐STAT3 or iExo mASO‐STAT3 treatments suppressed STAT3 levels and ECM deposition in established liver fibrosis in mice, and significantly improved liver function. iExo mASO‐Stat3 restored liver function more efficiently when compared to iExo siRNA‐STAT3 . Our results identify a novel anti‐fibrotic approach for direct targeting of STAT3 with exosomes with immediate translational potential.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1096/fj.202002777rr

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Cited by

See all 86

Metadata

Authors
Tang, M., Chen, Y., Li, B., Sugimoto, H., Yang, S., Yang, C., LeBleu, V. S., McAndrews, K. M., & Kalluri, R.
Venue
The FASEB Journal
Publisher
Wiley
Published
2021-04-14
Volume
35
Issue
5
Pages
e21557-e21557
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W3152837398
Cited by
86
References
19
FWCI
4.36
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis. https://app.cochat.ai/papers/10.1096/fj.202002777rr
The paper
Tang, M., Chen, Y., Li, B., Sugimoto, H., Yang, S., Yang, C., LeBleu, V. S., McAndrews, K. M., & Kalluri, R. (2021). Therapeutic targeting of STAT3 with small interference RNAs and antisense oligonucleotides embedded exosomes in liver fibrosis. The FASEB Journal. https://doi.org/10.1096/fj.202002777rr

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.